Redefining and revisiting cost estimates of routine ART care in Zambia: an analysis of ten clinics.

ABSTRACT:

Introduction

Accurate costing is key for programme planning and policy implementation. Since 2011, there have been major changes in eligibility criteria and treatment regimens with price reductions in ART drugs, programmatic changes resulting in clinical task-shifting and decentralization of ART delivery to peripheral health centres making existing evidence on ART care costs in Zambia out-of-date. As decision makers consider further changes in ART service delivery, it is important to understand the current drivers of costs for ART care. This study provides updates on costs of ART services for HIV-positive patients in Zambia.

Methods

We evaluated costs, assessed from the health systems perspective and expressed in 2016 USD, based on an activity-based costing framework using b

SUBMITTER: Tucker A 

PROVIDER: S-EPMC7025092 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature